Latest News & Features
Big Pharma
Despite its troubled start, Brazil’s Product Development Partnerships programme is now entering a new stage of its development with the introduction of a more complete system for regulation, but there’s also more scope for patent infringement, say Otto Licks and Ricardo Campello of Licks Attorneys. 16 July 2015
Asia
AstraZeneca has agreed a deal with drug maker Kyowa Hakko Kirin giving the UK pharmaceutical company the option to commercialise an asthma treatment in Japan. 16 July 2015
Americas
Japanese drug maker R-Tech Ueno has sued Apotex for patent infringement after the Canadian-based pharmaceutical company allegedly applied to create a generic version of one of its eye treatment drugs. 15 July 2015
Americas
US law firm Haynes and Boone has expanded its intellectual property practice by hiring two partners. 13 July 2015
Americas
Pharmaceutical company Teva has become the first business to launch a generic version of Janssen Pharmaceuticals’s migraine treatment drug Axert (almotriptan malate). 13 July 2015
Americas
Law firm Fenwick & West has expanded its life sciences practice by hiring Daniel Becker as partner. 10 July 2015
Biotechnology
The European Patent Office has invalidated a patent covering genetically modified mice and rats. 9 July 2015
Europe
Twenty-five years ago Tuerk and Gold reported the Selex method. Richard Clegg of Mewburn Ellis discusses some of the challenges at the EPO today when attempting to obtain adequate class-level protection for functionally defined molecules. 9 July 2015
Asia
India’s progressive IP policies—and its status as ‘pharmacy of the developing world’ and lifeline for millions of people—are now under threat from many fronts. Yuanqiong Hu, IP advisor for Médecins Sans Frontières’s Access Campaign, explains more. 9 July 2015
Americas
US law firm Lathrop & Gage has hired Amy McMahon to the firm’s intellectual property division. 9 July 2015